Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

North America: Largest market, powered by high drug consumption, strong regulatory frameworks, and advanced biotech manufacturing infrastructure. Asia Pacific: Fastest-growing, led by India's contract ...

Pakistan's pharmaceutical industry, valued at Rs. 748 billion, faces challenges with API imports. Localizing API production could enhance economic stability and healthcare affordability.

With a substantial manufacturing base already locked down in China, CRDMO BioDuro is taking a short jaunt down to Taiwan for its latest drug ingredients production play.  | BioDuro, headquartered in ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

After Zhejiang Huahai Pharmaceutical’s tainted valsartan API and Changchun Changsheng Life Sciences’ fabricated vaccine production data exposé, China’s drug industry could be dealing with another ...

Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing organizations (CDMOs) that claim to have potent ...

The National Drug Policy, 1982 marked a revolutionary shift in Bangladesh's pharmaceutical industry. Following its adoption, domestic production surged, local companies gained market dominance, and ...